ALOX5 and type 1 diabetes mellitus: Comparing T1D and nondiabetic controls, no differences were observed in the mRNA expressions of ALOX5 and MYD88 and in the plasma concentrations of LTB4 after adjustment for sex, age, and use of statins, ARB, and ACEI (Figures 1(a), 1(b), and 1(d), respectively).